Frier Levitt is a boutique law firm specializing in healthcare and life sciences law, offering comprehensive regulatory, transactional, and litigation services to a diverse clientele, including physicians, pharmacies, medical practices, surgery centers, laboratories, and other healthcare providers. The firm's mission is to empower healthcare entities with pragmatic solutions to complex legal challenges, delivered promptly and within budget. Established in 2000, Frier Levitt has grown to become a national leader in its field, with offices in Pine Brook, New Jersey, and New York City.
Key Strategic Focus
Frier Levitt concentrates on delivering specialized legal services tailored to the unique needs of the healthcare and life sciences sectors. The firm's core objectives include providing expert counsel on regulatory compliance, transactional matters, and litigation. By leveraging deep industry knowledge and a client-centric approach, Frier Levitt aims to navigate the complex legal landscape of healthcare, ensuring clients achieve their operational and strategic goals.
Financials and Funding
As of recent estimates, Frier Levitt generates annual revenues of approximately $23.5 million, with a revenue per employee of around $270,000. The firm employs approximately 87 individuals, reflecting a slight decrease in staff over the past year. Specific details regarding external funding or investment rounds are not publicly disclosed, indicating that the firm operates primarily on its generated revenue.
Leadership Team
Frier Levitt's leadership comprises experienced professionals dedicated to advancing the firm's mission:
- Daniel B. Frier: Co-Founder and Managing Partner, overseeing strategic direction and client relations.
- Jonathan E. Levitt: Co-Founder and Partner, specializing in healthcare litigation and regulatory matters.
- Michelle L. Greenberg: General Counsel, appointed in July 2022, bringing nearly two decades of experience with the firm to her role.
- John E. Morrone: Partner and head of the New York City office, focusing on life sciences regulatory and healthcare regulatory departments.
- Christopher Mayer: Partner, joined in June 2024, enhancing the firm's capabilities in healthcare and life sciences law.
- Matthew Kupferberg: Partner, joined in March 2024, contributing extensive experience in healthcare regulatory issues.
- Alex Keoskey: Partner, joined in March 2024, reinforcing the firm's expertise in healthcare and life sciences law.
- Brandon Zarsky: Promoted to Partner in December 2023, recognized for his contributions to the firm's growth.
- Harini Bupathi: Promoted to Partner in December 2023, acknowledged for her expertise and leadership within the firm.
- Todd Brower: Senior Vice President and General Counsel, appointed in September 2023, focusing on leadership and operational excellence.
- Elli Albert: Director of Administration, appointed in August 2022, responsible for human resources and staff management.
Leadership Changes
The firm has experienced significant leadership developments, including the appointment of Michelle L. Greenberg as General Counsel in July 2022, and the addition of partners such as Christopher Mayer, Matthew Kupferberg, and Alex Keoskey in 2024. These strategic hires and promotions reflect Frier Levitt's commitment to enhancing its expertise and expanding its service offerings.
Competitor Profile
Frier Levitt operates in a competitive landscape alongside other law firms specializing in healthcare and life sciences law. Notable competitors include:
- Nelson Hardiman: A law firm with approximately 36 employees and estimated revenues of $7.5 million, focusing on healthcare law.
- Hooper, Lundy & Bookman: Employing around 105 individuals with revenues of $16 million, offering comprehensive legal services in the healthcare sector.
- OFW Law: With 36 employees and revenues of $6.6 million, specializing in food and drug law.
These firms, along with others, contribute to a dynamic market characterized by a demand for specialized legal expertise in healthcare and life sciences.
Strategic Collaborations and Partnerships
Frier Levitt has expanded its national footprint by opening a Manhattan office in September 2019, located at 101 Greenwich Street. This strategic move enhances the firm's accessibility to clients in the New York metropolitan area and underscores its commitment to growth and client service.
Operational Insights
The firm's strategic considerations include maintaining a competitive position through continuous expansion and the addition of seasoned professionals to its team. By focusing on specialized legal services and fostering a collaborative work environment, Frier Levitt differentiates itself in the market.
Strategic Opportunities and Future Directions
Looking ahead, Frier Levitt aims to capitalize on opportunities for expansion by leveraging its current strengths in healthcare and life sciences law. The firm's strategic roadmap includes enhancing service offerings, exploring new markets, and continuing to attract top talent to meet the evolving needs of its clients.
Contact Information
- Website: Frier Levitt's commitment to providing specialized legal services, coupled with its strategic growth initiatives, positions the firm as a leader in healthcare and life sciences law.
